Tag Archives: US Federal Circuit of Appeals

BIO IP News Weekly for June 26, 2009

This week’s BIO IP News Weekly includes an analysis of Professor John Duffy in Business Week, an essay on technology transfer and university-industry collaboration in the Scientist Magazine, updates on USPTO funding and follow-on biologics, a blogger’s look at a U.S. Senator’s struggles to defend intellectual property rights, as well as a link to the recently published 2009 OECD Biotechnology Statistics report summary.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

CAFC Judge Rader: “Strong IP System Allows Countries to Compete in World Marketplace”

I recently discovered an interview series on the intellectual property system on YouTube, produced by CropLife International.  Of particular interest is the interview with U.S. Federal Circuit of Appeals (CAFC)  Judge Randall R. Rader (Watch: http://www.youtube.com/watch?v=tB3OROLi9IM). I liked the way Judge Rader defined intellectual property: a way to protect the “know-how” of any economic entity (company, university, and individual) to do business in today’s global marketplace. During the interview, Judge Rader focused on a part of the Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

IP Counsels Committee Conference in Phoenix Discusses Patent Reform

At the latest IP Counsels Committee Conference this past March, Q. Todd Dickinson, Executive Director of the American Intellectual Property Law Association (AIPLA), and E. Anthony Figg of Rothwell, Figg, Ernst & Manbeck, P.C., spoke to BIO’s member companies, universities, and law firm members about patent reform legislation. Patent Docs‘ Donald Zuhn wrote about Dickinson and Figg on Patent Reform yesterday: In the three weeks since the panel session took place, Senate Judiciary Committee Chairman Patrick Leahy Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

The Blunders of In Re Kubin

A recent U.S. Federal Circuit of Appeals decision (In Re Kubin) distorts the definition of a patentable invention, threatening the future of biotechnology innovation in the United States. Read our summary.

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,